- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Catechins and resveratrol from green tea neuroprotective for patients with herpes-induced AD
Using 2D and 3D human cortical tissue models that replicate physiologically significant disease characteristics, Isabella Silveira and colleagues have demonstrated a straightforward framework for quickly screening and identifying Alzheimer's Disease (AD) drugs of interest. This study was published in Free Radical Biology and Medicine.
An incapacitating and life-altering cognitive decline can result from Alzheimer's disease, a neurodegenerative condition. There are no treatments that can change the course of AD, and its origin is poorly known. The purpose of this study was to evaluate a panel of 21 drugs, dietary supplements, and nutraceuticals for their potential to provide neuroprotective benefits. The researchers used 2D and 3D tissue culture models of herpesvirus-induced AD, which recapitulate hallmark disease features such as plaque formation, neuroinflammation, gliosis, and impaired neuronal signaling.
Human foreskin fibroblasts were used to direct reprogram human-induced neural stem cells (hiNSCs). HSV-1 was introduced into these cells at a multiplicity of infection (MOI) of 0.0001. Models of the human cortical brain tissue in 3D were created. Viral inoculums were combined with experimental substances. While 3D models were maintained for 10 days and processed for calcium imaging and immunostaining, 2D cell cultures were maintained for a week and used for gene expression analysis and immunostaining. Cells that had been cultured in 2D cultures or 3D models underwent immunofluorescence. Beta-amyloid (A) plaque-like formations were measured for relative size and quantity.
The key findings of this study were:
1. This screening revealed that resveratrol and green tea catechins have potent anti-plaque properties, functional neuroprotective advantages, and little neurotoxicity, supporting further research into these compounds as AD preventives and treatments.
2. Citicoline and metformin, two further options, decreased plaque formation and had low toxicity, but they provided little protection against virus-induced alterations in neural signaling.
In conclusion, according to the study, resveratrol and green tea catechins are attractive candidates because of their anti-plaque effects, functional neuroprotective qualities against AD, and low toxicity. Although treatments with citicoline and metformin showed plaque reduction and low toxicity, these drugs were not effective in protecting against HSV-induced changes in neuronal transmission. Overall, using 2D cell cultures and 3D human brain tissue models, the work provided a straightforward platform for the quick screening and characterization of drugs against AD.
Reference:
Silveira, I. A., Mullis, A. S., Cairns, D. M., Shevzov-Zebrun, A., Whalen, J., Galuppo, A., Walsh, K. G., & Kaplan, D. L. (2022). Screening neuroprotective compounds in herpes-induced Alzheimer's disease cell and 3D tissue models. In Free Radical Biology and Medicine (Vol. 186, pp. 76–92). Elsevier BV. https://doi.org/10.1016/j.freeradbiomed.2022.05.002
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751